Search

Your search keyword '"Rothé, Françoise"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Rothé, Françoise" Remove constraint Author: "Rothé, Françoise" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
20 results on '"Rothé, Françoise"'

Search Results

1. Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

2. Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

3. Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

4. Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis

5. Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors

6. Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

7. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families

9. CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

10. ESR1 mutations in metastatic lobular breast cancer patients

12. Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

13. The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group

14. Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations

15. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations

16. Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer

18. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology

19. International study on inter-reader variability for circulating tumor cells in breast cancer

Catalog

Books, media, physical & digital resources